Comparative clinical pharmacology of cisplatin and carboplatin

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


The platinum compounds cisplatin and carboplatin are active against a wide range of adult and pediatric malignancies. Whereas both exert their cytotoxic effect by incorporating into DNA, they have substantially different systemic and cellular pharmacology. In addition, their toxicity profiles are much different. Substantial interpatient pharmacokinetic variability and narrow therapeutic indexes of the two agents led to the development of several dosing strategies. Although these strategies reduce pharmacokinetic variability, their effect on improving patient outcome remains to be determined.

Original languageEnglish (US)
Pages (from-to)140S-145S
Issue number5 II SUPPL.
StatePublished - Sep 1997
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Comparative clinical pharmacology of cisplatin and carboplatin'. Together they form a unique fingerprint.

Cite this